申请人:Hoffmann-La Roche Inc.
公开号:US04150132A1
公开(公告)日:1979-04-17
Alkyl or alkoxyalkyl 5-[3,6-dihydro-1(2H)-pyridyl]-2-oxo-2H-[1,2,4]-oxadiazolo-[2,3-a]primidine -7-carbamates, prepared, inter alia, from the corresponding 6-[3,6-dihydro-1(2H)-pyridyl]-2,4-pyrimidine-dicarbamate-3-oxide, are described. The end products are useful in the treatment of vascular-conditioned hypertension or as vasodilators in the case of peripheral blood supply disorders.
烷基或烷氧基烷基5-[3,6-二氢-1(2H)-吡啶基]-2-氧代-2H-[1,2,4]-噁二唑-[2,3-a]嘧啶-7-氨基甲酸酯,是从相应的6-[3,6-二氢-1(2H)-吡啶基]-2,4-嘧啶二氨基甲酸酯-3-氧化物制备而成的。最终产品在治疗血管条件性高血压或作为外周血液供应障碍的血管扩张剂方面具有用处。